Ever wonder how #resistance to #rapalogs develops in #RCC and why despite introduction ~20 yrs ago, mTOR mutations not found? @kcputsw provides some answers pnas.org/doi/10.1073/pn…

1. 🚨Excited to share our latest article, co-led with Talal El Zarif, MD, now published in Cell Reports! doi.org/10.1016/j.celr… Immense gratitude to my amazing mentors Sylvan Baca MD PhD (Hiring!) Toni Choueiri, MD #MatthewFreedman for their crucial support. #BacaLab Dana-Farber Lank Center for Genitourinary Oncology Yale Medicine

Ahmet Yıldırım Mohammad Jad Moussa, MD, MSc Zeynep Irem Ozay, MD Nazli Dizman Mehmet Asim Bilen,MD Bassel Nazha, MD, MPH Jacqueline T. Brown, MD You are so right Ahmet Yıldırım! Can’t wait for the next meeting to see all the friends we made at #ASCO2024 and meet new ones 😊 Zeynep Irem Ozay, MD Wadih Issa, MD Marc Machaalani Razane El Hajj Chehade Hedyeh Ebrahimi Renee Maria Saliby Bárbara Melão, MD Chadi Hage Chehade

In JACC Journals, we show that LA remodeling in AR patients had similar progression rates regardless of sex and age, with a higher prognostic value than LV parameters. Emmanuel Christine Jellis Milind Desai MD MBA Brian Griffin Cleveland Clinic Heart, Vascular & Thoracic CCF Cardiology Fellows jacc.org/doi/epdf/10.10…

Our UTSW Simmons Cancer Center trio enjoyed Association of American Cancer Institutes #CRI2024 — #ErinWilliams delivered an excellent talk & panel discussion about staff acuity metrics! Great conference for all things related to clinical research! Thanks to the Association of American Cancer Institutes staff & planning committee!!

Happy to see our UroCCR NEPRAH study published in European Urology Oncology @eurouroonc HUGO TAPIAS @AFU Ingels Alexandre Urologie CHU Mondor euoncology.europeanurology.com/article/S2588-… 29 🇫🇷 French centers 3451 Patients included

I'm pleased to share that Suzanne Conzen, M.D., Professor of Internal Medicine and Chief of Hematology & Oncology UT Southwestern Medical Center, has been appointed to serve as a member of the National Cancer Institute National Cancer Institute Board of Scientific Advisors. A huge honor!

Incredibly excited to be applying for #GIFellowship💩 Thrilled to be sharing this journey with my amazing fiancée and future #PedsGI star Rasha Abou Jaoudeh, MD🌟 #GIfellowship #PedsGIfellowship #match2025

What are the current simulation technologies in structural heart disease interventions? Read below 👇🏻 Serge C. Harb Cleveland Clinic Heart, Vascular & Thoracic JAHA ahajournals.org/doi/10.1161/JA…

Proud to announce that @charlesjiangmd and Glenda Delgado Ramos, MD have been awarded the Robert A. Winn Diversity in Clinical Trials: Career Development Awards (Winn CDAs)! 🌟📷 Learn more: diversityinclinicaltrials.org/winn-cda/ #WinnCDA #DiversityInClinicalTrials UT Southwestern Medical Center UTSW Simmons Cancer Center

Awesome — congrats Charles Jiang MD, MPH one of the John Quale Travel Fellows Bladder Cancer Advocacy Network #BCANTT24! Thanks Petros Grivas for supporting our rising star UTSW Hematology & Oncology UTSW Simmons Cancer Center UT Southwestern Medical Center!

1/ 🚨 Just in European Urology , our study on first-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma. Effort co-led with Talal El Zarif, MD, with amazing mentorship from Daniel Heng Toni Choueiri, MD sciencedirect.com/science/articl… Dana-Farber Lank Center for Genitourinary Oncology Yale School of Medicine OncoAlert

1/ Results from #LITESPARK-005 are out NEJM! The phase 3 trial that led to HIF-2 inhibitor Belzutifan (BEL) U.S. FDA approval Dec 2023 in pretreated pts w/ #ccRCC. Presentation #ESMO24 @myEsmo Check it out: nejm.org/doi/full/10.10…

⚡️What happens when “pastamigos” meet Uromigos 😃 Served with love 🍝🍽️ 🎧 Petros Grivas Brian Rini, MD Tom Powles

PSMA PET imaging and targeted therapies: a case study on high-risk localized #ProstateCancer. Tian Zhang, MD, MHS @UTSWNews and Elena Castro discuss in this Independent Medical Education Initiative on UroToday > bit.ly/3IdC7Rd Bayer | Pharmaceuticals

Toni Choueiri, MD presents #TiNivo2 showing no benefit of combination in IO-refractory #kidneycancer — supports tivozanib 1.34mg monotherapy. Results published in The Lancet today thelancet.com/journals/lance… #ESMO24 ESMO - Eur. Oncology #ESMOAmbassadors

silke gillessen presents #PEACE3 results — improved rPFS & prelim OS for enzalutamide with radium-223 for mCRPC. Notably few prior abi treated & many w prior docetaxel in mHSPC setting. Important role for radium in bone only met #prostatecancer. ESMO - Eur. Oncology #ESMO24 #ESMOAmbassadors

So excited to have #STAREV open UTSW Simmons Cancer Center & share #ESMO24 with QianJanieQin! EV and radiation before cystectomy to increase pathCR rates for cis-ineligible #bladdercancer ESMO - Eur. Oncology #ESMOAmbassadors OncoAlert UroToday.com

Just published in JACC Journals, first-in-human experience of performing percutaneous electrosurgery-guided perforation and balloon dilation of the anterior #MVL followed by #TMVR to prevent #LVOTO jacc.org/doi/10.1016/j.… Samir Kapadia Serge C. Harb Cleveland Clinic Heart, Vascular & Thoracic Parth Parikh

Congratulations to Dr. Andy Wang 🇺🇦, new #AAASFellow AAAS — our family is so proud of you & your contributions to medicine and science. May you continue to think outside of the box, create & innovate to push the boundaries in cancer & disease. UTSW Radiation Oncology UTSW Simmons Cancer Center UT Southwestern Medical Center